Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner

NCT ID: NCT05412407

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-18

Study Completion Date

2024-02-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

What are the terms of use of analgesics for acute pain on an outpatient basis before a consultation with a general practitioner? Descriptive epidemiological study of patients in general practice in Rhône-Alpes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Questionnaire : Taken analgesics

the patient will complete a questionnaire

Group Type OTHER

Questionnaire

Intervention Type OTHER

description of analgesic self-medication in the context of acute pain using a questionnaire evaluating the drug taken, the dosage, the duration of treatment, the type of pain, its intensity, the origin of the drug, the source of information consulted and the factors that prompted the patient to self-medicate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

description of analgesic self-medication in the context of acute pain using a questionnaire evaluating the drug taken, the dosage, the duration of treatment, the type of pain, its intensity, the origin of the drug, the source of information consulted and the factors that prompted the patient to self-medicate

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patient
* without cognitive impairment
* having acute pain for less than 3 months
* Consultant to the practices participating to the study.

Exclusion Criteria

* Patients who do not understand French
* Patients protected by law
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Assad ACHIQ

Role: PRINCIPAL_INVESTIGATOR

Médecins remplaçants

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MSP Hauteville

Hauteville-Lompnes, , France

Site Status RECRUITING

MSPU bel-air

Saint-Priest, , France

Site Status RECRUITING

Maison de santé de Malissol

Vienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Assad ACHIQ

Role: CONTACT

+33755385765

Toufik KHAYI

Role: CONTACT

+33698030629

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

assad achiq

Role: primary

07 55 38 57 65

Assad ACHIQ

Role: primary

07 55 38 57 65

assad achiq

Role: primary

07 55 38 57 65

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL22_0050

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Paracetamol and Pharmacogenetic
NCT01520792 COMPLETED PHASE1
Antagonistic Interaction CB1-paracetamol
NCT00750347 COMPLETED PHASE1